Intravenous Prochlorperazine Dosing for Vomiting
For adults with acute vomiting, administer prochlorperazine 2.5 to 10 mg IV by slow injection or infusion at a rate not exceeding 5 mg per minute, with a maximum single dose of 10 mg and total daily IV dose not exceeding 40 mg. 1
Adult Dosing
The FDA-approved dosing is clear and should guide practice:
- Initial dose: 2.5 to 10 mg IV
- Administration rate: Maximum 5 mg per minute (slow push or infusion)
- Maximum single dose: 10 mg
- Maximum daily IV dose: 40 mg
- Repeat dosing: May repeat if necessary, but stay within daily maximum
- Preparation: Can be given undiluted or diluted in isotonic solution
- Critical warning: Do NOT use bolus injection 1
Practical Approach
Start with 2.5 mg IV for most patients. Research supports this lower dose as effective—one study showed 32 of 35 patients (91%) responded to 2.5-5 mg total, with mean time to cessation of vomiting of 8.5 minutes 2. If no response within 20 minutes, repeat the dose up to the 10 mg maximum per dose.
Elderly patients require special consideration: Use lower range dosing as they are more susceptible to hypotension and neuromuscular reactions. Titrate carefully and monitor closely 1.
Pediatric Dosing
For children ≥2 years old and ≥20 pounds with severe nausea and vomiting, calculate dose as 0.06 mg per pound (0.132 mg/kg) body weight by deep IM injection. 1
Critical Pediatric Contraindications and Warnings
- DO NOT USE in pediatric surgery 1
- DO NOT USE in children under 20 pounds or under 2 years of age 1
- Children are more prone to extrapyramidal reactions even at moderate doses—use lowest effective dose 1
- Exercise particular caution in children with acute illnesses or dehydration 1
- A systematic review found extrapyramidal symptoms occurred in 9% (single-dose) to 4% (multiple-dose) of pediatric patients, with rare but serious adverse events including seizures and neuroleptic malignant syndrome 3
Safety Considerations
Hypotension Risk
Hypotension is a significant concern with IV administration. This is why:
- Slow administration (≤5 mg/min) is mandatory
- Bolus injection is contraindicated
- Monitor blood pressure during and after administration 1
Extrapyramidal Symptoms
Monitor for dystonic reactions, akathisia, and restlessness. Have diphenhydramine available for treatment of dystonic reactions (or benztropine if diphenhydramine allergy exists) 4. Research shows akathisia occurred in approximately 9% of patients receiving prochlorperazine 10 mg IV 5.
Comparative Effectiveness
A randomized trial comparing ondansetron 4 mg to prochlorperazine 10 mg IV found both equally effective for controlling vomiting, though prochlorperazine provided superior nausea control at 31-120 minutes (p=0.03-0.05) 5. However, a Cochrane review found no convincing evidence of superiority of any antiemetic over placebo in the ED setting, with placebo groups often showing clinically significant improvement 6.
Route Considerations
IV route is preferred over IM when rapid control is needed—IV administration achieved cessation of vomiting in mean 8.5 minutes versus 35 minutes for IM (p<0.05) 2. Subcutaneous administration is contraindicated due to local irritation 1.
Common Pitfalls
- Avoid bolus injection: Always give as slow push or infusion
- Don't exceed rate limits: 5 mg/min maximum to prevent hypotension
- Don't use in young children: Absolute contraindication under 2 years/20 pounds
- Monitor for sedation: Can be significant, particularly at higher doses
- Watch for drug interactions: Increased sedation risk when combined with other CNS depressants